Calcification and the usual suspect phosphate: Still guilty but there are other guys behind the scenes

Nephrology Dialysis Transplantation

Volumn 21, Issue 1, 2006, Pages 33-35

  Ketteler, Markus ^a   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; PHOSPHATE; PYROPHOSPHATE;

ARTERY CALCIFICATION; ARTICLE; BONE MINERALIZATION; DIALYSIS; HYPOPHOSPHATEMIA; KIDNEY FAILURE; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; CALCINOSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MICE; MICE, KNOCKOUT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS;

EID: 30344437601     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi270     Document Type: Article

References (12)

1. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17
2. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867
3. Ketteler M, Westenfeld R, Schlieper G et al. "Missing" inhibitors of calcification: General aspects and implications in renal failure. Pediatr Nephrol 2005; 20: 383-388
4. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 2003; 361: 827-833
5. Stenvinkel P, Wang K, Axelsson J et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383-2392
6. Wang AYM, Woo J, Lam CWK et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-1685
7. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
8. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187
9. Murshed M, Harmey D, Millan JL, McKee JD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 2005; 19: 1093-1104
10. Lomashvili KA, Khawandi W, O'Neill WC. Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 2005; 16: 2495-2500
11. Amann K, Ritz E. Cardiovascular abnormalities in ageing and in uraemia-only analogy or shared pathomechanisms? Nephrol Dial Transplant 1998; 13 [Suppl 7]: 6-11
12. Ketteler M, Brandenburg V, Jahnen-Dechent W, Westenfeld R, Floege J. Do not be misguided by guidelines: The calcium × phosphate product can be a Trojan horse. Nephrol Dial Transplant 2005; 20: 673-677